武汉云克隆科技股份有限公司

EGF样域蛋白7(EGFL7)多克隆抗体

Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7)

ZNEU1; MEGF7; Zneu1; Vascular endothelial statin; EGF Like Domain Containing 7; Epidermal growth factor-like protein 7; Multiple epidermal growth factor-like domains protein 7

  • EGF样域蛋白7(EGFL7)多克隆抗体产品包装(模拟)
  • EGF样域蛋白7(EGFL7)多克隆抗体产品包装(模拟)
  • EGF样域蛋白7(EGFL7)多克隆抗体DAB staining on IHC-P; Samples: Human Placenta Tissue; Primary Ab: 30µg/ml Rabbit Anti-Human EGFL7 Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • EGF样域蛋白7(EGFL7)多克隆抗体DAB staining on IHC-P;
    Samples: Human Kidney Tissue;
    Primary Ab: 30µg/ml Rabbit Anti-Human EGFL7 Antibody
    Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • PAL643Hu01.jpgFigure. Western Blot; Sample: Recombinant EGFL7, Human.
  • EGF样域蛋白7(EGFL7)多克隆抗体Western Blot; Sample: Lane1: Human Placenta lysate; Lane2: Mouse Liver lysate
    Primary Ab: 4µg/ml Rabbit Anti-Human EGFL7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对EGFL7的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别EGFL7。

用法

Western blottin:g: 0.01-5µg/mL;
Immunohistochemistry: 5-50µg/mL;
Immunocytochemistry: 5-50µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
RPL643Hu01EGF样域蛋白7(EGFL7)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAL643Hu01EGF样域蛋白7(EGFL7)多克隆抗体WB; IHC; ICC; IP.
MAL643Hu21EGF样域蛋白7(EGFL7)单克隆抗体WB; IHC; ICC; IP.
SEL643HuEGF样域蛋白7(EGFL7)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LML643HuEGF样域蛋白7(EGFL7)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
PGL643Hu01EGF样域蛋白7(EGFL7)引物对PCR

参考文献

杂志参考文献
Scientific ReportsPrognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab[PMC5443778]
Scientific ReportsPrognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab.[pubmed:28539619]
International Journal of Clinical and Experimental PathologyEGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells[ISSN:1936-2625]
Cancer Drug ResistMicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy[]